Synlogic is a biopharmaceutical company based in Cambridge, Massachusetts, pioneering the development of a novel class of therapeutics, called synthetic biotics, based on its proprietary synthetic biology and microbiome platform. Synlogic's synthetic biotics are engineered probiotic bacteria that perform specific metabolic functions from the gut microbiome to correct missing or dysfunctional metabolic activities throughout the body.
